30 pharmaceutical companies such as Johnson & Johnson oppose the OTC advertising ban
30 large OTC companies are opposed to fear of devastating blows in the industry
The representative of the enterprise asked the SFDA: "It is not us who violate the law. Why are we beaten?"
The latest revision of the Drug Advertising Review Act prohibits the distribution of drugs, including over-the-counter drugs (OTCs), in the mass media. China's over-the-counter drug association recently took the lead in convening nearly 30 large-scale OTC production companies to hold a seminar in Beijing, and Xing Yong, deputy director of the State Food and Drug Administration Inspection Bureau, discussed the feasibility of prohibiting OTC drugs from advertising in the mass media. However, nearly 30 OTC companies attending the seminar unanimously opposed.
New revision content first exposure
Zhao Zhi, the chairman of Hezhong Communication, which is officially certified by Sina Weibo, posted the first page of the “Measures for Drug Advertisements Review” (revised draft) on its Weibo. The second article reads: "The drug name, drug indication (function) or other content related to the drug is a drug advertisement. The drug must be jointly designated by the health administrative department of the State Council and the food and drug supervision and administration department of the State Council. Advertising on medical and pharmaceutical professional publications may not publish advertisements in the mass media or otherwise publicize the advertisements for the public." "Only promote the name of the drug (including the generic name of the drug and the name of the drug product), or not involved Drug indications (functions and indications) corporate image ads that are not related to drugs, no need to review."
This is the first exposure of the latest revision of the Drug Advertising Review, and it has once again confirmed the previous rumors that the state intends to ban all drugs, including over-the-counter (OTC) advertising on the mass media.
Nearly 30 companies are in unison
In response to the newly revised content, commissioned by the State Food and Drug Administration, on September 28, the China Non-Prescription Drug Association invited 30 pharmaceutical companies to conduct research. It is understood that the large-scale OTC production enterprises participated in the seminar on that day, and also the "big households" of OTC drug advertisements, such as Xi'an Yangsen, China Resources Sanjiu, Jiangzhong Pharmaceutical, Sino-US Shike, Johnson & Johnson, Harbin Pharmaceutical, Kang Enbei, Renhe. Groups wait, but they are strongly opposed.
Xi’an Yangsen’s media director Gao said that OTC drug advertising has taken on a large number of tasks to educate consumers, raise public awareness of the disease, and fully give people the right to know about the use of drugs. If the prohibition of OTC advertising on the mass media, it may not only deprive consumers of the right to know about the use of drugs, but also affect the two interest chains of the upstream, downstream and downstream industries involved in the OTC advertising and related industries.
Jiangzhong Pharmaceutical is a manufacturing company all supported by OTC products. 70% of Renhe Pharmaceutical's products are also OTC, which is spread by a large number of mass media and is almost a household name. What they are most worried about is that if the ban is issued, it will have a devastating impact on the company's development.
Drug advertising illegal rate reached 58.2%
Although the pharmaceutical companies are totally opposed, there are people in the industry who do not want to be named to discuss it privately: "A large number of illegal drug advertisements, and many of them are not subject to censorship. Local TV stations broadcast directly, and the impact is very bad. This allows the national drug supervision. The bureau is very passive."
Xing Yong revealed at the seminar that the illegal drug advertisements in China, including counterfeit drugs and super-indications, were very rampant, and the serious illegal advertising rate has reached 58.2%. The current situation of extremely chaotic market has caused the government to pay close attention to it. The State Food and Drug Administration has made up its mind to vigorously rectify and eliminate those who violate the law.
However, representatives of Renhe Pharmaceuticals asked the officials of the Food and Drug Administration: "It is not us who violate the law. Why are we beaten?" The Director of Government Affairs of Jiangzhong Pharmaceutical Group also suggested: "The government should increase the crackdown on illegal drug advertisements. If any company, including Jiangzhong Pharmaceutical, dares to do something illegal, it should be punished for bankruptcy."
However, Xing Yong said that whether this regulation has been revised or not has not been determined. Now it is only entering the stage of collecting opinions, and when it is revised, there is no specific timetable. (Reporter Lu Zhilin